Spironolactone

Hazard statements (CLP)

H302, H315, H336, H360, H362, H373

Code

Statements

H302

Harmful if swallowed

2.1 Classification of the substance or mixture

Regulation (EC) No 1272/2008 Acute toxicity - Oral Category 4 - (H302) Skin corrosion/irritation Category 2 - (H315) Reproductive toxicity Category 1B - (H360) Effects on or via lactation Yes - (H362) Specific target organ toxicity — single exposure Category 3 - (H336) Specific target organ toxicity — repeated exposure Category 2 - (H373)

2.2 Label elements

200-133-6

Contains

Spironolactone

Signal word

Danger

Hazard statements

H302 - Harmful if swallowed H315 - Causes skin irritation H336 - May cause drowsiness or dizziness H360 - May damage fertility or the unborn child H362 - May cause harm to breast-fed children H373 - May cause damage to organs through prolonged or repeated exposure

Precautionary statements

P201 - Obtain special instructions before use P260 - Do not breathe dust/fume/gas/mist/vapours/spray P263 - Avoid contact during pregnancy and while nursing P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves/protective clothing/eye protection/face protection P501 - Dispose of contents/ container to an approved waste disposal plant

2.3 Other hazards

This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information Chemical name EU - REACH (1907/2006) - Article 59(1) EU - REACH (1907/2006) - Endocrine - Candidate List of Substances of Very Disruptor Assessment List of High Concern (SVHC) for Authorisation Substances Spironolactone -